Stay updated with breaking news from Lophora Aps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The antipsychotic drugs market is expanding rapidly due to the increasing prevalence of mental disorders such as schizophrenia, schizoaffective disorder,...
The antipsychotic drugs market is expanding rapidly due to the increasing prevalence of mental disorders such as schizophrenia, schizoaffective disorder, bipolar disorder, severe depression
Under an R&D partnership Beckley Psytech, dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, will jointly fund continuing development of Lophora ApS’ pipeline of proprietary NCEs for treatment-resistant depression, and other potential indications such as anxiety, post-traumatic stress disorder and substance abuse. Click to read more...
Beckley Psytech bolsters pipeline of next-generation psychedelic medicines with research collaboration and strengthening of relationship with Lophora ApS Beckley Psytech to collaborate with Lophora on researching New Clinical Entities (NCE’s) Broad collaboration with Lophora will further strengthen Beckle...